Figure 5. The proportion of patients who achieved Boolean remission 2.0 in FINCH 1 (A), FINCH 2 (B) and FINCH 3 (C) (safety analysis set, NRI). Patients with missing outcomes were set as non-responders. Error bars show 95% CIs. FIL(100/200), filgotinib (100 mg/200 mg); NRI, non-responder imputation.